期刊文献+

床旁凝血功能监测的临床应用进展

下载PDF
导出
摘要 传统的凝血功能测试法如凝血酶原如间(PT)、部分凝血酶原时间(PPT)、血小板计数(PLT)和纤维蛋白原浓度(FIB)等,常常不能直接反映凝血障碍的原因,亦达不到监测凝血的目的。床旁即时评估全血黏弹性的凝血功能检测设备(POC设备)的出现,使血液分析不需要在实验室而是在患者病床旁完成,从而缩短了周转时间。而且用全血评估凝血状态,可模拟体内凝血系统与血小板和红细胞之间的相互作用,其结果反映了血小板功能。同时,凝血块的形成过程可被实时显示,还实现了在患者实际体温下分析凝血功能。
出处 《中国医刊》 CAS 2012年第5期29-31,共3页 Chinese Journal of Medicine
  • 相关文献

参考文献17

  • 1Lier H, Bottiger BW, Hinkelbein J, et al. Coagulation management in multiple trauma: a systematic review [ J]. Intensive Care Med. 2011,37 (4) : 572 -582.
  • 2Levi M, Schultz M, van der Poll T. Coagulation biomarkers in criti- cally ill patients[ J]. Crit Care Clin,2011,27 (2) : 281 - 297.
  • 3Kashuk JL, Moore EE, Wohlauer M, et al. Initial experiences with point-of-care rapid thrombelastography for management of life-threat- ening postinjury coagulopathy[ J]. Transfusion,2011, 25: 10.
  • 4常小丽,黄慧玲,王琴,梁建伟,莫丽冬,王辰,范维佳,李晓茜.牛磺酸对大鼠脑创伤凝血状态影响的研究[J].创伤外科杂志,2010,12(4):355-357. 被引量:2
  • 5Llewellyn RL, James MF. The effect of low molecular weight heparin (enoxaparin) on enhanced coagulation induced by crystalloid hae- modilution [ J ]. Anaesthesia. 2010,65 (10) : 1013.
  • 6Sieders E, De Somer F, Bouchez S, et al. Haemostasis monitoring during sequential aortic valve replacement and liver transplantation [ J ]. Acta Gastroenterol Belg, 2010,73 ( 1 ) : 65 - 68.
  • 7Brown C, Joshi B, Faraday N, et al. Emergency cardiac surgery in patients with acute coronary syndromes: a review of the evidence and perioperative implications of medical and mechanical therapeutics [ J ]. Anesth Analg,2011,112 (4) : 777 - 799.
  • 8曲东.脓毒症患者凝血功能改变及治疗对策[J].中国医刊,2008,43(11):20-23. 被引量:9
  • 9Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinieal use of viscoelastic point-of-care coagulation devices [ J ]. Anesth Analg,2008,106(5 ) : 1366 - 1375.
  • 10吴志云,蔡骅,张诚华,王永盛,陈建洪.Sonoclot分析在创伤性休克患者手术期凝血功能障碍的应用研究[J].中国综合临床,2007,23(2):168-169. 被引量:4

二级参考文献17

  • 1李金芳,周荫庄,屠淑洁.牛磺酸对细胞的保护功能[J].首都师范大学学报(自然科学版),2006,27(1):63-66. 被引量:31
  • 2李钢,徐如祥,柯以铨.颅脑损伤后凝血紊乱研究的新进展[J].中华神经医学杂志,2006,5(6):646-648. 被引量:22
  • 3徐玮,沈宏.重型颅脑损伤后凝血功能变化的研究[J].浙江创伤外科,2007,12(2):98-101. 被引量:11
  • 4李秀萍,冯国良,高励聪.牛磺酸的治疗作用及机制研究进展[J].包头医学,2007,31(1):26-28. 被引量:9
  • 5Ten Care H. Pathophysiology of disseminated intravaseular coagulation in sepsis[J]. Crit Care Med, 2000,28(9supple):S9 -S11.
  • 6Menges T, Hermans PW, Little SG, et al. Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients[J]. Lancet, 2001,357: 1096 - 1097.
  • 7Yan SB, Heherbrand JD, Hartman DL, et al. Low levels of protein C are associated with poor outcomes in severe sepsis [ J ]. Chest, 2001,120:915 -922.
  • 8Warren BL, Eid A, Singer P, et al. Caring for the critically ill patirnts. High-dose antithrombin Ⅲ in severe sepsis: A randomized controlled trial[ J]. JAMA, 2001,286: 1869 - 1578.
  • 9Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis [ J ]. New Engl J Med, 2001,344(10) : 699 -709.
  • 10Barton P, Kalil AC, Nadel S, et al. Safety, pharmacokinetics and ppharmacodynamics of drotrecogin alfa ( activated ) in children with severe sepsis [ J ]. Pediatrics, 2004,113 ( 1 Pt 1 ) : 7 - 17.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部